MacroGenics | Bienes



Assets Cambio Fecha
AbbVie USD 135.16B 8.26B 2024-12
Amgen USD 91.84B 956M 2024-12
AstraZeneca USD 104.04B 887M 2024-12
Biogen USD 28.05B 263.9M 2024-12
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Daiichi Sankyo JPY 3.46T 12.51B 2025-03
Eli Lilly USD 78.71B 3.11B 2024-12
Genmab DKK 45.81B 6.15B 2024-12
Geron USD 593.78M 148.83M 2024-12
Gilead Sciences USD 56.43B 2.56B 2025-03
J&J USD 180.1B 1.82B 2024-12
MacroGenics USD 261.65M 2.84M 2024-12
Merck USD 117.11B 426M 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Regeneron Pharmaceuticals USD 37.76B 317.5M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Xencor USD 951.94M 31.69M 2024-12



MacroGenics Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.